USPTO serial 77556402
ARGYLL BIOTECHNOLOGIES
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- YOUNG, CARRIE SKYE
- Law office
- LAW OFFICE 117 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with ARGYLL BIOTECHNOLOGIES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mary S. Mathew
MARY S. MATHEW THELEN REID BROWN RAYSMAN & STEINER LLP875 3RD AVENEW YORK, NY 10022-6225UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Regulatory submission management and compliance, including assisting others in preparing and filing applications for new biopharmaceutical and pharmaceutical goods with governmental regulatory bodies, obtaining regulatory approvals, and maintaining compliance with regulatory requirements; business management services relating to product manufacturing, storage and delivery, operations management services, supply chain, and production systems, distribution solutions, marketing, and production in the field of biopharmaceuticals and pharmaceuticals | ACTIVE | — |
| 042 | Scientific and medical research; biopharmaceutical and pharmaceutical research and development; testing or inspection of biopharmaceuticals and pharmaceuticals; development of treatments and therapies in the fields of biopharmaceuticals and pharmaceuticals; regulatory compliance consulting as it applies to biopharmaceuticals and pharmaceuticals; monitoring, analysis and consultation pertaining to after sale product safety of biopharmaceutical and pharmaceutical goods | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 22, 2009 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jul 21, 2009 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Dec 10, 2008 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 10, 2008 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 10, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 3, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 29, 2008 | NWAP | NEW APPLICATION ENTERED | — |